210 related articles for article (PubMed ID: 26425691)
21. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
[TBL] [Abstract][Full Text] [Related]
22. Caspase expression in oral squamous cell carcinoma.
Coutinho-Camillo CM; Lourenço SV; Nishimoto IN; Kowalski LP; Soares FA
Head Neck; 2011 Aug; 33(8):1191-8. PubMed ID: 21755562
[TBL] [Abstract][Full Text] [Related]
23. Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy.
Nayak S; Bhatt MLB; Goel MM; Gupta S; Mahdi AA; Mishra A; Mehrotra D
PLoS One; 2018; 13(6):e0199665. PubMed ID: 29953521
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.
Fang KH; Kao HK; Chi LM; Liang Y; Liu SC; Hseuh C; Liao CT; Yen TC; Yu JS; Chang KP
Laryngoscope; 2014 Sep; 124(9):E354-60. PubMed ID: 24706327
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
26. Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.
Kumar M; Matta A; Masui O; Srivastava G; Kaur J; Thakar A; Shukla NK; RoyChoudhury A; Sharma M; Walfish PG; Michael Siu KW; Chauhan SS; Ralhan R
J Transl Med; 2015 Aug; 13():285. PubMed ID: 26318153
[TBL] [Abstract][Full Text] [Related]
27. A Three Long Noncoding RNA-Based Signature for Oral Squamous Cell Carcinoma Prognosis Prediction.
Zhao C; Zou H; Wang J; Shen J; Liu H
DNA Cell Biol; 2018 Nov; 37(11):888-895. PubMed ID: 30234381
[TBL] [Abstract][Full Text] [Related]
28. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
29. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
[TBL] [Abstract][Full Text] [Related]
30. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.
Bose P; Klimowicz AC; Kornaga E; Petrillo SK; Matthews TW; Chandarana S; Magliocco AM; Brockton NT; Dort JC
BMC Cancer; 2012 Aug; 12():332. PubMed ID: 22852863
[TBL] [Abstract][Full Text] [Related]
31. [A novel prognostic index for oral cancer in Fujian province].
Wu JF; Lin LS; Chen F; Liu FQ; Yan LJ; Bao XD; Wang J; Wang R; Lin LK; Qiu Y; Zheng XY; Hu ZJ; Cai L; He BC
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):841-846. PubMed ID: 29936758
[No Abstract] [Full Text] [Related]
32. The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients.
Wang Y; Hu H; Wang Q; Li Z; Zhu Y; Zhang W; Wang Y; Jiang H; Cheng J
Pathol Res Pract; 2017 Aug; 213(8):969-974. PubMed ID: 28554766
[TBL] [Abstract][Full Text] [Related]
33. Silencing DNA Polymerase β Induces Aneuploidy as a Biomarker of Poor Prognosis in Oral Squamous Cell Cancer.
Wang HC; Chan LP; Wu CC; Chang SJ; Moi SH; Luo CW; Pan MR
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673690
[TBL] [Abstract][Full Text] [Related]
34. High Expression of Tomm34 and Its Correlations With Clinicopathology in Oral Squamous Cell Carcinoma.
Cai M; Tan R; Huang Y; Chen X; Kong Q; Guo K; Xu M
Pathol Oncol Res; 2021; 27():641042. PubMed ID: 34257607
[TBL] [Abstract][Full Text] [Related]
35. NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.
Arora R; Haynes L; Kumar M; McNeil R; Ashkani J; Nakoneshny SC; Matthews TW; Chandarana S; Hart RD; Jones SJM; Dort JC; Itani D; Chanda A; Bose P
Cancer Gene Ther; 2023 May; 30(5):752-765. PubMed ID: 36635327
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
37. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
38. A novel and independent survival prognostic model for OSCC: the functions and prognostic values of RNA-binding proteins.
Wang S; Liu S; Zhu Y; Zhang B; Yang Y; Li L; Sun Y; Zhang L; Fan L; Hu X; Huang C
Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):397-409. PubMed ID: 37656222
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for oral squamous cell carcinoma.
Wu CS; Chang KP; Chen LC; Chen CC; Liang Y; Hseuh C; Chang YS
Oral Oncol; 2012 Jun; 48(6):516-22. PubMed ID: 22321252
[TBL] [Abstract][Full Text] [Related]
40. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]